Regulatory response to contaminated valsartan von Banzi, Rita, Bertele’, Vittorio

Volltext

Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU von Joppi, Roberta, Bertele’, Vittorio, Garattini, Silvio

Volltext

Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicines von Garattini, Silvio, Bertele’, Vittorio

Volltext

Approvals of drugs with uncertain benefit–risk profiles in Europe von Banzi, Rita, Gerardi, Chiara, Bertele', Vittorio, Garattini, Silvio

Volltext

Letting post-marketing bridge the evidence gap: the case of orphan drugs von Joppi, Roberta, Gerardi, Chiara, Bertele’, Vittorio, Garattini, Silvio

Volltext

Conditional approval of medicines by the EMA von Banzi, Rita, Gerardi, Chiara, Bertele’, Vittorio, Garattini, Silvio

Volltext

Non-inferiority trials are unethical because they disregard patients' interests von Garattini, Silvio, Prof, Bertele', Vittorio, Dr

Volltext

Older patients are still under-represented in clinical trials of Alzheimer's disease von Banzi, Rita, Camaioni, Paolo, Tettamanti, Mauro, Bertele', Vittorio, Lucca, Ugo

Volltext

Clinical evidence supporting the marketing authorization of biosimilars in Europe von Allocati, Eleonora, Bertele’, Vittorio, Gerardi, Chiara, Garattini, Silvio, Banzi, Rita

Volltext

Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approval von Joppi, Roberta, Bertele, Vittorio, Vannini, Tommaso, Garattini, Silvio, Banzi, Rita

Volltext

A meritorious move against homeopathy von Garattini, Silvio, Bertele', Vittorio

Volltext

Funding is not enough von Garattini, Silvio, Bertele', Vittorio

Volltext

Marketing masked as clinical research. The Phase IIIB studies and other sample cases von Bertele’, Vittorio, Gerardi, Chiara, Garattini, Silvio

Volltext

Make pharma justify the price of drugs von Bertele', Vittorio, Garattini, Silvio

Volltext

Looking for safety but overlooking efficacy: Non-inferiority trials of anti-diabetics von Bertele', Vittorio, Banzi, Rita, Gerardi, Chiara, Garattini, Silvio

Volltext

New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials von Pecoraro, Valentina, Banzi, Rita, Cariani, Elisabetta, Chester, Johanna, Villa, Erica, D'Amico, Roberto, Bertele', Vittorio, Trenti, Tommaso

Volltext

Ethics in clinical research von Garattini, Silvio, Bertele’, Vittorio

Volltext

A disease looking for innovative drugs: The case of pulmonary arterial hypertension von Joppi, Roberta, Gerardi, Chiara, Bertele', Vittorio, Garattini, Silvio

Volltext

Clinical research on rare diseases of children: neuroblastoma von Gerardi, Chiara, Banzi, Rita, Bertele’, Vittorio, Garattini, Silvio

Volltext

EMA's transparency seems to be opaque von Banzi, Rita, Bertele', Vittorio, Garattini, Silvio

Volltext